Variable | All | Chemotherapy only | Allo-HSCT | P value |
---|---|---|---|---|
Total | 88 | 43 | 45 | – |
Age (years) | 36 (14–60) | 42 (14–60) | 36 (14–54) | 0.36 |
Malesa | 47 (53%) | 19 (44%) | 28 (62%) | 0.13 |
WBC (×109/L) | 8.3 (1.3–112) | 8.1 (1.3–112) | 8.6 (1.2–83) | 0.41 |
Blast cells percentage in the bone marrow (%) | 46% (18%–87%) | 46% (23%–87%) | 48% (18%–83%) | 0.82 |
Platelet count (×109/L) | 29 (4–187) | 30 (5–187) | 28 (4–106) | 0.38 |
Other cytogenetic abnormality than t(8;21)a | 54 (64%) | 24 (59%) | 30 (70%) | 0.36 |
RUNX1-RUNX1T1 transcript level | 466% (97%–2545%) | 532% (186%–2545%) | 422% (97%–933%) | 0.31 |
C-KIT mutationa | 30 (34%) | 15 (35%) | 15 (33%) | 1.00 |